Nalaganje...

Safety and efficacy of icatibant self-administration for acute hereditary angioedema

We evaluated the efficacy and safety of icatibant self-administration in 15 patients with hereditary angioedema (HAE) types I or III, for 55 acute attacks (mostly severe or very severe). Icatibant self-administration was generally effective: first symptom improvement occurred in 5 min–2 h (HAE type...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Boccon-Gibod, I, Bouillet, L
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Publishing Ltd 2012
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3390482/
https://ncbi.nlm.nih.gov/pubmed/22519593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2249.2012.04574.x
Oznake: Označite
Brez oznak, prvi označite!